In order to engage more Americans in primary care, we need to understand the main challenges that surround primary care in the U.S., according to Dr. Stephen Ezeji-Okoye, Crossover Health's chief medical officer. Some of these include the increasing shortage of primary care physicians and the lack of incentivization to focus on whole-person health and preventive care.
Planning for the strategic use of a low-code platform helps provide long-term benefits and helps to avoid issues resulting from suboptimal use of the products.
This new whitepaper from Ventech Solutions offers helpful guidance for how to mitigate the hidden risks low-code platforms present. It also presents a list of recommendations for addressing these challenges.
By flipMD and MedCity News Tuesday, October 25, 2022 7:30 AM
Join us in this webinar presented by flipMD and learn how to remain at the forefront of healthcare and adapt to patients' needs, business leader, and leverage physician insights.
By Stephanie Baum Tuesday, October 25, 2022 7:30 AM
Alviss.ai CEO and Founder Dr. Pavel Overtchouk talks about how the company's stroke prediction software seeks to be the first attempt to apply predictive medicine to cardiovascular interventions and heart surgery.
In an opinion published Friday by Ninth Circuit Judge Ronald Gould said, "Invoking journalism and the First Amendment does not shield individuals from liability for violations of laws applicable to all members of society."
AstraZeneca drug Imjudo is now FDA approved for treating advanced liver cancer. The infused therapy is administered under a novel dosing schedule in addition to Imfinzi, an AstraZeneca drug already approved for treating several different types of cancer.
Cofertility is a new startup aiming to make egg freezing more accessible by tying it to egg donation. The startup offers women two programs: Keep and Split. With Keep, women can pay to freeze their eggs and store them all for their own later use. The Split program allows women to freeze their eggs for free when they give half to a family who can't otherwise conceive.
Specialty carve outs that move specialty drugs away from traditional prescription drug management to a pharmacy benefit administrator (PBA) or specialty administrator will continue and likely to provide cost savings.
By Frank Vinluan Monday, October 24, 2022 12:30 PM
The second patient who died in the Phase 1 test of Alpine Immune Sciences cancer drug, davoceticept, reportedly suffered the same cardiovascular complication as the first patient. The biotech company is stopping enrollment in two clinical tests of the drug and assessing all participants in the studies.
By Dietrich A. Stephan Monday, October 24, 2022 9:00 AM
There is no arguing that the last year has been a rocky one for biotech companies, but trends suggest that the sector is ready for an upswing. The revenue model works, innovation continues to bear fruit, and the need is ever-present. The harsh winter will result in a hearty harvest.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments